About Embryotech Laboratories
Embryotech Laboratories is a Healthcare company based in Haverhill (United States) founded in 1994, and was acquired by Hamilton Thorne in September 2016. It operates as a toxicity testing assays. The company has 12 employees. Its chief executive is Tyler Dean. Embryotech Laboratories offers products and services including Mouse Embryo Assays, Bacterial Endotoxin Testing, Human Sperm Assays, Bioburden Testing, and Embryos and Ova Products. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is EMBRYOTECH LABORATORIES INC. Its competitors include Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Embryotech Laboratories was founded in 1994 and is based in Haverhill, United States, within the biotechnology sector focused on toxicity testing. Products and services, such as mouse embryo assays, 1-cell or 2-cell mouse embryos for quality control, Limulus Amebocyte Lysate Assay (LAL), Human Sperm Survival Assay (HuSSA), and Mouse IVF Assay, are developed. Operations are conducted under strict GMP guidelines, with accurate Certificates of Analysis provided.
- Headquarters Haverhill, United States
- Employees 12
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website embryotech.com
- Social LinkedIn X Facebook Instagram
- Acquired by Hamilton Thorne (Sep 2016)
- Legal Name Embryotech Laboratories Inc.
- Investors
- Employee Count12
- Acquired byHamilton Thorne
(Sep 2016)
Products & Services of Embryotech Laboratories
Embryotech Laboratories offers a comprehensive portfolio of products and services, including Mouse Embryo Assays, Bacterial Endotoxin Testing, Human Sperm Assays, Bioburden Testing, and Embryos and Ova Products.
Used for toxicity and functionality testing of mouse embryos.
Detects endotoxins via Gel-Clot LAL and Kinetic Turbidimetric methods.
Performs toxicity and functionality tests on human sperm samples.
Measures microorganisms on medical devices for quality control.
Provides cryopreserved and fresh embryos for scientific research.
Investors in Embryotech Laboratories
Embryotech Laboratories has secured backing from 1 investor. Prominent investors backing the company include Hamilton Thorne.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Precision laser devices and advanced image analysis systems for the fertility, stem cell and development biology | 2002 | hamiltonthorne.com | Beverly, United States |
Investor details for Embryotech Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Embryotech Laboratories
1 people are tracked at Embryotech Laboratories (1 in leadership); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Tyler Dean | CEO | Leadership |
Complete people profiles for Embryotech Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Embryotech Laboratories
2 dated milestones of Embryotech Laboratories across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Embryotech Laboratories is founded.
- Exit Acquired by Hamilton Thorne.
Competitors of Embryotech Laboratories
Embryotech Laboratories has 9 listed competitors in our database, 6 of them funded. They include Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. |
Detailed competitors of Embryotech Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Embryotech Laboratories
The website of Embryotech Laboratories (embryotech.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▼ 4.9% vs previous month
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Embryotech Laboratories (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Embryotech Laboratories
Embryotech Laboratories was founded in 1994.
Embryotech Laboratories is headquartered in Haverhill, United States. It is registered at Haverhill, Massachusetts, United States.
Tyler Dean is the current CEO of Embryotech Laboratories.
Embryotech Laboratories has 12 employees.
Embryotech Laboratories was founded in 1994 and is based in Haverhill, United States, within the biotechnology sector focused on toxicity testing. Products and services, such as mouse embryo assays, 1-cell or 2-cell mouse embryos for quality control, Limulus Amebocyte Lysate Assay (LAL), Human Sperm Survival Assay (HuSSA), and Mouse IVF Assay, are developed. Operations are conducted under strict GMP guidelines, with accurate Certificates of Analysis provided.
Embryotech Laboratories's top competitors include Abcam, Biocare Medical and Sino Biological.
Embryotech Laboratories offers Mouse Embryo Assays, Bacterial Endotoxin Testing, Human Sperm Assays, Bioburden Testing, and Embryos and Ova Products.
Embryotech Laboratories has 1 investor. Key investors include Hamilton Thorne.
Embryotech Laboratories operates through Embryotech Laboratories Inc..
Yes. Embryotech Laboratories was acquired by Hamilton Thorne in September 2016.